Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
208
Recruiting, any sponsor type, condition "pneumonia"
By trial status
The same filters, counted in each status. Pick one to switch.
- Recruiting208
- Completed2,406
208 trials
Showing 1 to 25, recently updated first.
University of California, San DiegoAcademic, hospital or other
NCT05553743 · 5,000 participants (planned) · Start Mar 27, 2014 · Primary completion Mar 2040
Drug: COVID-19 Exposure; Antibiotic · For: Breastfeeding; COVID-19 Infection; COVID-19 Vaccine and 2 more
Sites: San Diego, California
- Improving Vaccine Efficacy for People With Helminth Infection: CORBEVAX in EthiopiaPivotal-lookingRecruiting
University of AarhusAcademic, hospital or other
NCT07948395 · 150 participants (planned) · Start Oct 10, 2026 · Primary completion Apr 30, 2027
Drug: Biological: CORBEVAX · For: Schistosomiasis Mansoni; Hookworm Infection; COVID-19
Sites: Bahir Dar, Ethiopia
- Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit WardPivotal-lookingRecruiting
Nantes University HospitalAcademic, hospital or other
NCT06229288 · 326 participants (planned) · Start Apr 25, 2024 · Primary completion May 25, 2027
Drug: Amoxicillin; Amoxicillin/clavulanate · For: Community-acquired Pneumonia
Sites: Angers, France; Bobigny, France; Brest, France · 19 sites in all
- A Superiority Study of Model-Guided Optimized Dosing Versus Empirical Dosing of Piperacillin/Tazobactam in the Treatment of Community-Acquired Pneumonia in Elderly PatientsPivotal-lookingRecruiting
Shandong UniversityAcademic, hospital or other
NCT07945275 · 118 participants (planned) · Start Jul 17, 2026 · Primary completion May 31, 2027
Drug: Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®) · For: PD Target Attainment Rate; Pneumonia; Elderly (People Aged 65 or More)
Sites: Jinan, China
Oorja Bio, Inc.Industry
NCT07869147 · 95 participants (planned) · Start Nov 2026 · Primary completion Jan 2029
Drug: ORJ-001 · For: Idiopathic Pulmonary Fibrosis
Sites: Birmingham, Alabama; Doral, Florida; DuBois, Pennsylvania
- Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.Pivotal-lookingRecruiting
St. Justine's HospitalAcademic, hospital or other
NCT03031210 · 1,370 participants (planned) · Start Jun 11, 2017 · Primary completion Jun 1, 2027
Drug: Amoxicillin · For: Community-acquired Pneumonia
Sites: Montreal, Canada
Op-T LLCIndustry
NCT06669403 · 26 participants (planned) · Start Mar 9, 2026 · Primary completion Mar 2027
Drug: OPT101 · For: Sepsis; Community Acquired Pneumonia (CAP)
Sites: Denver, Colorado; Valhalla, New York
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)Pivotal-lookingRecruiting
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT06667700 · 3,082 participants (planned) · Start Dec 2, 2024 · Primary completion Jan 26, 2031
Drug: Molnupiravir; Placebo · For: Coronavirus Disease (COVID-19)
Sites: Cullman, Alabama; Paradise Valley, Arizona; Phoenix, Arizona · 230 sites in all
- A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe DiseasePivotal-lookingRecruiting
ShionogiIndustry
NCT07743580 · 2,000 participants (planned) · Start Sep 14, 2026 · Primary completion Jun 30, 2028
Drug: Secutrelvir; Placebo · For: SARS-CoV-2
Sites: Coral Gables, Florida; Hialeah, Florida; Miami, Florida · 52 sites in all
- Effect of Single High-Dose Vitamin D3 Versus Placebo on Hospital Length of Stay in Children With Severe Pneumonia.Pivotal-lookingRecruiting
Shaheed Mohtarma Benazir Bhutto Institue of TraumaAcademic, hospital or other
NCT07938489 · 114 participants (planned) · Start Jul 1, 2026 · Primary completion Nov 15, 2026
Drug: Vitamin D3 Group; Placebo (Peanut Oil Solution) · For: Severe Pneumonia in Children
Sites: Lahore, Pakistan
- Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryPivotal-lookingRecruiting
ECOG-ACRIN Cancer Research GroupResearch network
NCT02734537 · 189 participants (planned) · Start Nov 23, 2016 · Primary completion Dec 31, 2027
Drug: Cisplatin · For: Head and Neck Squamous Cell Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Laryngeal Squamous Cell Carcinoma and 13 more
Sites: Birmingham, Alabama; Anchorage, Alaska; Fairbanks, Alaska · 679 sites in all
Incyte CorporationIncyte (INCY)
NCT07124078 · 60 participants (planned) · Start May 20, 2026 · Primary completion Jan 31, 2029
Drug: INCA034176; Best available Treatment (BAT) · For: Chronic Graft-versus-host-disease
Sites: Duarte, California; Los Angeles, California; Palo Alto, California · 42 sites in all
- A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseasePivotal-lookingRecruiting
Incyte CorporationIncyte (INCY)
NCT06585774 · 240 participants (planned) · Start Jan 21, 2025 · Primary completion Sep 28, 2027
Drug: INCA034176; Placebo and 1 more · For: Chronic Graft-versus-host-disease
Sites: Birmingham, Alabama; Tucson, Arizona; Duarte, California · 133 sites in all
IMMUNOe Research CentersIndustry
NCT07932002 · 30 participants (planned) · Start Nov 5, 2025 · Primary completion Jul 31, 2027
Drug: Ruconest · For: Post SARS-CoV2 (COVID-19); Post-Viral Fatigue Syndrome; Post-Viral Disorder (Disorder) and 1 more
Sites: Centennial, Colorado
- Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruiting
Novartis PharmaceuticalsNovartis (NVS)
NCT07354074 · 50 participants (planned) · Start Apr 28, 2026 · Primary completion Feb 23, 2033
Drug: Asciminib single agent · For: Chronic Myelogenous Leukemia; Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Sites: Chicago, Illinois; New Brunswick, New Jersey; New York, New York · 39 sites in all
National Cancer Institute (NCI)NIH
NCT04959175 · 320 participants (planned) · Start Sep 23, 2021 · Primary completion Apr 27, 2027
Drug: Mycophenolate Mofetil; Fludarabine and 4 more · For: Hematologic Neoplasms
Sites: Bethesda, Maryland; Philadelphia, Pennsylvania
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of AgePivotal-lookingRecruiting
ModernaTX, Inc.Moderna (MRNA)
NCT07808697 · 300 participants (planned) · Start Sep 4, 2026 · Primary completion Aug 30, 2029
Drug: mRNA-1283; mRNA-1273 · For: SARS-CoV-2
Sites: Ontario, California; Miami, Florida; Miami Lakes, Florida · 31 sites in all
National Cancer Institute (NCI)NIH
NCT05327023 · 430 participants (planned) · Start May 23, 2022 · Primary completion Jul 3, 2028
Drug: Cyclophosphamide; Busulfan and 3 more · For: Hematologic Neoplasms
Sites: Bethesda, Maryland
- A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host DiseasePivotal-lookingRecruiting
SanofiSanofi (SNY)
NCT07771439 · 356 participants (planned) · Start Oct 12, 2026 · Primary completion Sep 14, 2029
Drug: Belumosudil · For: Chronic Graft Versus Host Disease
Sites: Amsterdam, Netherlands; Madrid, Spain · 3 sites in all
- A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing FormulationsPivotal-lookingRecruiting
ModernaTX, Inc.Moderna (MRNA)
NCT07863635 · 600 participants (planned) · Start Oct 9, 2026 · Primary completion Dec 11, 2026
Drug: mRNA-1273; mRNA-1283 · For: SARS-CoV-2
Sites: Overland Park, Kansas; Louisville, Kentucky; Charlotte, North Carolina · 5 sites in all
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaPivotal-lookingRecruiting
UMC UtrechtAcademic, hospital or other
NCT02735707 · 20,000 participants (planned) · Start Apr 11, 2016 · Primary completion Jun 2028
Drug: Ceftriaxone + Macrolide; Moxifloxacin or Levofloxacin and 47 more · For: Respiratory Tract Diseases; Influenza (Pandemic); Influenza and 7 more
Sites: Jacksonville, Florida; Augusta, Georgia; Chicago, Illinois · 408 sites in all
- Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHDRecruiting
Sarah Nikiforow, MDAcademic, hospital or other
NCT06991361 · 21 participants (planned) · Start May 29, 2026 · Primary completion May 1, 2029
Drug: EVE-Treg · For: Graft Versus Host Disease (cGvHD)
Sites: Boston, Massachusetts
M.D. Anderson Cancer CenterAcademic, hospital or other
NCT06434363 · 47 participants (planned) · Start Jul 31, 2024 · Primary completion Dec 31, 2028
Drug: Tafasitamab; Fludarabine phosphate and 2 more · For: Autoimmune Disorders; Systemic Sclerosis; Systemic Lupus Erythematosus and 2 more
Sites: Houston, Texas · 2 sites in all
- CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIALPivotal-lookingRecruiting
Hellenic Institute for the Study of SepsisAcademic, hospital or other
NCT07834346 · 252 participants (planned) · Start Sep 16, 2026 · Primary completion Oct 2029
Drug: Placebo; clarithromycin · For: Sepsis
Sites: Pátrai, Greece; Athens, Greece; Ioannina, Greece · 19 sites in all
Henry M. Jackson Foundation for the Advancement of Military MedicineAcademic, hospital or other
NCT07287137 · 54 participants (planned) · Start Nov 12, 2025 · Primary completion Sep 2027
Drug: Pfizer-BioNTech mRNA COVID-19 vaccine; Novavax recombinant protein vaccine · For: COVID -19; COVID - 19; COVID 19 and 5 more
Sites: Bethesda, Maryland
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.